{"id":153486,"date":"2022-11-02T10:14:35","date_gmt":"2022-11-02T17:14:35","guid":{"rendered":"https:\/\/clarius.com\/blog\/podcast-les-femmes-se-declarent-plus-satisfaites-des-examens-gynecologiques-a-domicile-lheure-de-limagerie-ultrasonore-pilotee-par-le-patient-a-t-elle-sonne\/"},"modified":"2026-03-13T09:23:18","modified_gmt":"2026-03-13T16:23:18","slug":"podcast-les-femmes-se-declarent-plus-satisfaites-des-examens-gynecologiques-a-domicile-lheure-de-limagerie-ultrasonore-pilotee-par-le-patient-a-t-elle-sonne","status":"publish","type":"post","link":"https:\/\/clarius.com\/fr\/blog\/podcast-les-femmes-se-declarent-plus-satisfaites-des-examens-gynecologiques-a-domicile-lheure-de-limagerie-ultrasonore-pilotee-par-le-patient-a-t-elle-sonne\/","title":{"rendered":"[PODCAST] Les femmes se d\u00e9clarent plus satisfaites des examens gyn\u00e9cologiques \u00e0 domicile. L’heure de l’imagerie ultrasonore pilot\u00e9e par le patient a-t-elle sonn\u00e9 ?"},"content":{"rendered":"

\nTurtle Health is seeking FDA clearance to bring at-home gynecological exams and fertility testing with transvaginal ultrasonography to market<\/em>. <\/p>\n

\nThere\u2019s no question that smartphones and tablets have given rise to a myriad of healthcare monitoring tools that are helping us stay healthier and more fit. But is it time for us to be able to use ultrasound to monitor what\u2019s going on in our bodies?<\/p>\n

\nIf you ask Amy Zwanziger, Co-Founder and CEO of Turtle Health, the answer is a resounding \u201cyes!\u201d Zwanziger is on a mission to enable at-home gynecological ultrasound exams<\/a>, including fertility testing, by enabling women to use transvaginal ultrasound. <\/p>\n

\u00a0<\/p>\n

<\/p>\n

\n

Women have a fundamental right to information about their bodies, and we founded Turtle Health to empower women to access information when they need and want it, from the convenience and privacy of home,\u201d says Amy Zwanziger, Co-Founder and CEO of Turtle Health. \u201cWe are delighted that new data support clear at-home visualization of the uterus and ovaries in a diverse range of women, which can be used for a variety of gynecological applications.\u201d\n<\/p><\/blockquote>\n

\nA study funded by Turtle Health and published in the April 2022 edition of the Journal of Obstetrics and Gynecology<\/a> shows that self-administered transvaginal ultrasound exams guided remotely by a trained technologist are comparable to in-clinic ultrasonography in producing clinical-quality images and assessing antral follicle count to estimate ovarian reserve, which is an important element in evaluating a women\u2019s reproductive potential. <\/p>\n

\n

In a head-to-head crossover trial, participants performed self-administered virtual transvaginal ultrasonography at home guided by a remote-certified technologist, and then repeated the exam in-clinic,\u201d says Turtle Health Co-Founder Josh Haselkorn. \u201cThe uterus and ovaries were visualized with ultrasound using the Clarius EC7 HD3<\/a> transvaginal scanner. Independent, blinded reproductive endocrinologists reviewed the ultrasound cine clips captured and confirmed that antral follicle counts were equivalent across settings. We\u2019re thrilled that the study results show the efficacy of virtual transvaginal ultrasonography, and moreover, that participants reported greater satisfaction with their at-home experience.\u201d \n<\/p><\/blockquote>\n

\nTurtle Health\u2019s at-home testing solution uses the Clarius EC7 HD3<\/a> handheld wireless ultrasound scanner that works with the Clarius Ultrasound App on tablets. To perform the test, a trained technologist connects with the patient using Clarius Live telemedicine to provide real-time guidance for capturing clinical-quality images, which are subsequently sent for analysis. <\/p>\n

\nTurtle Health is currently seeking regulatory authorization to use the Clarius scanner in this novel context. The study, and associated regulatory filing, are under review by the U.S. Food and Drug Administration (FDA).<\/p>\n

\n

We\u2019re delighted to see the results of this research showing the efficacy of using Clarius ultrasound to empower virtual women\u2019s health. Our easy-to-use wireless endocavity scanner, combined with the power of artificial intelligence, connection to the cloud, and one-touch telemedicine, offer a unique solution for patient engagement,\u201d says Clarius President Ohad Arazi. \u201cAt Clarius, we\u2019re working with partners to deliver highly specialized ultrasound imaging solutions to market. We\u2019re pleased to work with Turtle Health to make gynecological care virtual and unlock access to affordable, patient-enabled ultrasound imaging.\u201d\n<\/p><\/blockquote>\n

<\/p>\n

Tech Zone Podcast – L’\u00e9chographie artificielle \u00e0 domicile ?<\/strong><\/h2>\n

<\/p>\n

\nArazi and Zwanziger recently engaged in a provocative discussion about the merits of ultrasound use at home during a podcast on the Tech Zone by Paul Amadeus Lane<\/a> of ABC News Radio. <\/p>\n

\nBoth CEOs were quick to respond to the question about how the pandemic helped push the boundaries of healthcare options.<\/p>\n

Ecoutez \u00ab\u00a0EP. 229-02-AI L’\u00e9chographie \u00e0 domicile\u00a0\u00bb sur Spreaker.<\/a>